JacquelineBlairStoneMD

Neuro-Oncology

Assistant Attending, Memorial Sloan Kettering Cancer Center

Overview of Dr. Stone

Dr. Jacqueline Stone is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from New York University Grossman School of Medicine and has been in practice 8 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 30 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(231) 508-9685

Fax+1 929-321-5028

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2013 - 2015
New York Presbyterian Hospital (Cornell Campus)Chief Residency, Neurology, 2012 - 2013
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2009 - 2013
New York University School of MedicineClass of 2009

Certifications & Licensure

NY State Medical License 2013 - 2026
CT State Medical License 2023 - 2025
NJ State Medical License 2022 - 2025
PA State Medical License 2022 - 2024
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesNeuro-oncology

Publications & Presentations

PubMed

A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.
Christian Grommes, Subhiksha Nandakumar, Lauren R Schaff, Igor Gavrilovic, Thomas J Kaley
Clinical Cancer Research. 2024-09-13
Curriculum Innovation: A Resident-Created Multiple-Choice Question of the Week to Augment Case-Based Learning.
Melvin Parasram, Shamelia Y Loiseau, Andrea S Yoo, Jacqueline B Stone, Judy H Ch'ang
Neurology. Education. 2024-03-01
1 citations
Fast, light, and scalable: harnessing data-mined line annotations for automated tumor segmentation on brain MRI.
Nathaniel C Swinburne, Vivek Yadav, Krishna Nand Keshava Murthy, Pierre Elnajjar, Hao-Hsin Shih
European Radiology. 2023-09-01

Abstracts/Posters

Phase Ib of Copanlisib in Combination with Ibrutinib in Recurrent/Refractory Primary CNS Lymphoma (PCNSL)
Jacqueline B Stone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019